A Study on BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and Clopidogrel
Status:
Recruiting
Trial end date:
2022-03-31
Target enrollment:
Participant gender:
Summary
The purpose of this clinical study is to determine whether the addition of an oral Factor XIa
Inhibitor to Aspirin and Clopidogrel is more effective than standard therapy in secondary
stroke prevention.